50 articles
Jakob Dahlberg, CEO and co-founder at Joint Academy discusses a research study published in "JAMA Network Open" (Feb 23, 2021) that found clinically imp...
Allen Burton, MD, Medical Director at Abbott Neuromodulation, discusses the DISTINCT trial (Dorsal spInal cord STImulatioN vs mediCal management for the...
Lead developer, Yasmeen Almog, a data scientist on Amgen's Digital Health and Innovation Team discusses Crystal Bone, a new digital health algorithm und...
Mike Clayman, co-founder and CEO of Flexion Therapeutics discusses their FDA approved drug ZILRETTA® ((triamcinolone acetonide extended-release injecta...
Medical Immunology at UCB, and a rheumatologist, discusses the recent update by the ICD-10 Coordination and Maintenance Committee (a subcommittee of the...
Cyrus Cooper, president of the International Osteoporosis Foundation (IOF) and professor of Musculoskeletal Science at the University of Oxford, discuss...
Doug Beall, MD, from the Oklahoma Spine Hospital, discusses ways to educate patients about PMO, the connection to fractures, and current treatment options.
Dr Joshua Hirsch from Massachusetts General Hospital and Liz Thompson, CEO of the National Osteoporosis Foundation, discuss back injuries resulting from...
Mike Clayman, CEO of Flexion, a biopharmaceutical company focusing on musculoskeletal conditions, talks about the preclinical studies on FX201, a locall...
Mike Clayman, discusses the company’s inflection year ahead, gene therapy, the importance of non-opioid options for people suffering from pain, and at...